Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery
Condition:   Pain, Post-operative Interventions:   Drug: Meloxicam Injection 30mg;   Drug: Meloxicam Injection 60mg;   Drug: Nacl 0.9% Sponsors:   Beijing Tide Pharmaceutical Co., Ltd;   The Third Xiangya Hospital of Central South University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials

Pain Relief After PrimaryTKA
Condition:   Pain, Postoperative Interventions:   Drug: Zynrelef (Bupivacaine 60 MG / Meloxicam 1.8 MG) Per 2.3 ML Extended Release Solution;   Drug: Bupivacaine HCl 0.5% Injectable Solution;   Procedure: primary total knee replacement Sponsor:   Rothman Institute Orthopaedics Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2023 Category: Research Source Type: clinical trials